Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia

European Journal of Nuclear Medicine

Volumn 26, Issue 3, 1999, Pages 239-245

  Pávics, László ^a   Grünwald, Frank ^b   Reichmann, Karl ^b   Horn, Rolf ^b   Kitschenberg, Anna ^b   Hartmann, Alexander ^b   Menzel, Christian ^b   Schomburg, Axel G ^b   Overbeck, Bettina ^b   Csernay, László ^a   Biersack, Hans J ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE

Author keywords

Acetazolamide test; Alzheimer's disease; Regional cerebral blood flow single photon emission tomography; Technetium 99m hexamethyl propylene amine oxime; Vascular dementia

Indexed keywords

ACETAZOLAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PHOTON EMISSION TOMOGRAPHY;

ACETAZOLAMIDE; AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0032991365     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050383     Document Type: Article

References (29)

1. 1. Evans DA, Taylor JO, Hennekens CH, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551-2556.
2. 2. Wells C, ed. Dementia. Philadelphia: Davis; 1977: 250.
3. 3. Loeb C. Clinical criteria for the diagnosis of vascular dementia. Eur Neurol 1988; 28: 87-92.
4. 4. Liston EH, La Rue A. Clinical differentiation of primary degenerative and multi-infarct dementia: a critical review of the evidence. Part I. Clinical studies. Biol Psychiatry 1983; 18: 1451-1467.
5. 5. Jellinger K, Danielkczyk W, Fisher P, et al. A clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990; 95: 239-258.
6. 6. Boller F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989; 38: 76-79.
7. 7. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988; 24: 50-56.
8. 8. Blessed DG, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
9. 9. Bonte FJ, Hom J, Tinter R, et al. Single photon tomography in Alzheimer's disease and the dementias. Semin Nucl Med 1990; 20: 342-352.
10. 10. Butler RE, Costa DC, Katona CLE. PET and SPET imaging in the dementias. In: Murray IPC, E11 PJ, eds. Nuclear medicine in clinical diagnosis and treatment. Edinburgh: Churchill Livingstone; 1994: 613-627.
11. 11. Tikofsky RS, Hellman RS. Brain single photon emission computed tomography: new activation and intervention studies. Semin Nucl Med 1991; 21: 40-57.
12. 12. Devous MD, Brass LM. SPET imaging in cerebrovascular disease. In: Murray IPC, E11 PJ, eds. Nuclear medicine in clinical diagnosis and treatment. Edinburgh: Churchill Livingstone; 1994: 559-574.
13. 13. Pávics L, Grünwald F, Barzó P, et al. Evaluation of cerebral vasoreactivity by single photon emission tomography and transcranial Doppler sonography using the acetazolamide test. Nuklearmedizin 1994; 33: 239-243.
14. 14. Vorstup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate of oxygen. J Clin Invest 1984; 74: 1634-1639.
15. 15. Hauge A, Nicolaysen G, Thoresen M. Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 1983; 117: 233-239.
16. 16. Bonte FJ, Devous MD, Reisch JS, et al. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single photon emission computed tomography. Invest Radiol 1989; 24: 99-103.
17. 17. Bonte FJ, Devous MD, Reisch JS. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single photon emission tomography. Invest Radiol 1988; 23: 564-568.
18. 18. Hachinski VC, Iliff LD, Phil M, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637.
19. 19. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centres. Neurology 1992; 42: 473-480.
20. 20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA work group under the auspices of Department of Health and Human Services task forces on Alzheimer's disease. Neurology 1984; 34: 939-944.
21. 99mTc-HMPAO. J Nucl Med 1988; 29: 572-573.
22. 22. Holman BL, Carvalho PA, Zimmerman RE, et al. Brain perfusion SPET using an annular single crystal camera: initial clinical experience. J Nucl Med 1990; 31: 1456-1561.
23. 23. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPET. J Nucl Med 1992; 33: 181-185.
24. 24. Reichmann K, Grünwald F, Menzel C, et al. Programmpaket zur semiquantitativen Auswertung und graphischen Darstellung der Gehirndurchblutung. Nuklearmedizin 1996, 35: A18.
25. 25. Knapp WH, Dannenberg C, Marschall B, et al. Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function. Eur J Nucl Med 1996; 23: 878-888.
26. 26. Meyer JS, Shirai T, Akiyama H. Neuroimaging for differentiating vascular from Alzheimer's dementias. Cerebrovasc Brain Metab Rev 1996; 8: 1-10.
27. 27. Kuwabara Y, Ichiya Y, Otsuka M, et al. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type. Stroke 1992; 23:594-598.
28. 28. Heun R, Kramer G, Knappertz VA. Vasomotor reactivity in dementia of Alzheimer type. Int J Geriatr Psychiatry 1994; 9:913-918.
29. 29. Rogers SL, Friedhoff LT. Long term efficacy and safety of donepezil in treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol 1998; 8: 67-75.